Saqi, A., Leslie, K. O., Moreira, A. L., Lantuejoul, S., Shu, C. A., Rizvi, N. A., Sonett, J. R., Tajima, K., Sun, S. W., Gitlitz, B. J., & Colby, T. V. (2022). Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice. JTO Clinical and Research Reports, 3(5), 100310. https://doi.org/10.1016/j.jtocrr.2022.100310

Canterbury, C. R., Fernandes, H., Crapanzano, J. P., Murty, V. V., Mansukhani, M. M., Shu, C. A., Szabolcs, M., & Saqi, A. (2021). ALK Gene Rearrangements in Lung Adenocarcinomas: Concordance of Immunohistochemistry, Fluorescence In Situ Hybridization, RNA In Situ Hybridization, and RNA Next-Generation Sequencing Testing. JTO Clinical and Research Reports, 2(10), 100223. https://doi.org/10.1016/j.jtocrr.2021.100223

Gebremariam, T. H., Haisch, D. A., Fernandes, H., Huluka, D. K., Binegdie, A. B., Woldegeorgis, M. A., Ergetie, W., Worku, A., Zerihun, L. M., Cohen, M., Massion, P. P., Sherman, C. B., Saqi, A., & Schluger, N. W. (2021). Clinical Characteristics and Molecular Profiles of Lung Cancer in Ethiopia. JTO Clinical and Research Reports, 2(7), 100196. https://doi.org/10.1016/j.jtocrr.2021.100196

Lagos, G. G., Feldman, J. L., Saqi, A., & Shu, C. A. (2021). Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report. JTO Clinical and Research Reports, 2(2), 100130. https://doi.org/10.1016/j.jtocrr.2020.100130